Literature DB >> 22476134

[Thoracic aortic aneurysm].

D Kotelis1, P Geisbüsch, M Hakimi, D Böckler.   

Abstract

Thoracic aortic aneurysms (TAA) are the most common pathology of the thoracic aorta. TAA are occuring with increasing incidence (10.4 cases per 100,000 person years) and are most commonly caused by atherosclerosis. There are also hereditary, inflammatory and infectious pathogenic factors. A TAA initially causes no symptoms and is therefore usually diagnosed as an incidental finding. Computed tomography angiography (CTA) and magnetic resonance angiography (MRA) are the diagnostic tools of choice for diagnosis and treatment planning. The mean growth rate of TAA is estimated to be 0.10 to 0.42 cm per year. A diameter of 6 cm is considered to be an indication for surgery. Besides medicinal therapy, thoracic endovascular aortic repair (TEVAR) nowadays offers certain advantages compared to conventional open repair. The same applies to the region of the aortic arch. Follow up examinations after TEVAR are of major importance in order to ensure long-term therapeutic success.

Entities:  

Mesh:

Year:  2012        PMID: 22476134     DOI: 10.1007/s00104-011-2242-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  20 in total

1.  Reporting standards for thoracic endovascular aortic repair (TEVAR).

Authors:  Mark F Fillinger; Roy K Greenberg; James F McKinsey; Elliot L Chaikof
Journal:  J Vasc Surg       Date:  2010-10       Impact factor: 4.268

Review 2.  Aortic debranching procedures to facilitate endografting.

Authors:  Mark K Eskandari
Journal:  Perspect Vasc Surg Endovasc Ther       Date:  2006-12

3.  Aortic arch replacement using selective cerebral perfusion.

Authors:  Teruhisa Kazui; Katsushi Yamashita; Naoki Washiyama; Hitoshi Terada; Abul Hasan Muhammad Bashar; Kazuchika Suzuki; Takayasu Suzuki
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

Review 4.  Total vs hemi-aortic arch transposition for hybrid aortic arch repair.

Authors:  Drosos Kotelis; Philipp Geisbüsch; Nicolas Attigah; Ulf Hinz; Alexander Hyhlik-Dürr; Dittmar Böckler
Journal:  J Vasc Surg       Date:  2011-08-31       Impact factor: 4.268

5.  Risk of spinal cord ischemia after endograft repair of thoracic aortic aneurysms.

Authors:  E C Gravereaux; P L Faries; J A Burks; V Latessa; D Spielvogel; L H Hollier; M L Marin
Journal:  J Vasc Surg       Date:  2001-12       Impact factor: 4.268

6.  Complications after aortic arch hybrid repair.

Authors:  Philipp Geisbüsch; Drosos Kotelis; Matthias Müller-Eschner; Alexander Hyhlik-Dürr; Dittmar Böckler
Journal:  J Vasc Surg       Date:  2011-01-07       Impact factor: 4.268

7.  Initial observations of endovascular aneurysm repair using Dyna-CT.

Authors:  Kari Ravn Eide; Asbjørn Ødegård; Hans Olav Myhre; Olav Haraldseth
Journal:  J Endovasc Ther       Date:  2007-02       Impact factor: 3.487

8.  Superior nationwide outcomes of endovascular versus open repair for isolated descending thoracic aortic aneurysm in 11,669 patients.

Authors:  Raja R Gopaldas; Joseph Huh; Tam K Dao; Scott A LeMaire; Danny Chu; Faisal G Bakaeen; Joseph S Coselli
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11       Impact factor: 5.209

9.  Short and midterm results after left subclavian artery coverage during endovascular repair of the thoracic aorta.

Authors:  Drosos Kotelis; Philipp Geisbüsch; Ulf Hinz; Alexander Hyhlik-Dürr; Hendrik von Tengg-Kobligk; Jens R Allenberg; Dittmar Böckler
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

10.  Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts.

Authors:  Lars G Svensson; Nicholas T Kouchoukos; D Craig Miller; Joseph E Bavaria; Joseph S Coselli; Michael A Curi; Holger Eggebrecht; John A Elefteriades; Raimund Erbel; Thomas G Gleason; Bruce W Lytle; R Scott Mitchell; Christoph A Nienaber; Eric E Roselli; Hazim J Safi; Richard J Shemin; Gregorio A Sicard; Thoralf M Sundt; Wilson Y Szeto; Grayson H Wheatley
Journal:  Ann Thorac Surg       Date:  2008-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.